Bio2 Technologies
Woburn, US
Biotech
Founders & leadership
RI
Richard IntraterDirector
DG
Donald GrimmDirector
CB
Cheryl BlanchardDirector
GJ
Gary JacobsDirector
DL
Debora LaBuddeDirector
PN
Paul Nichols, Jr.Executive Officer, Director
AO
Arthur O'DeaExecutive Officer
DK
Douglas KohrsDirector
Reported raises · per SEC filings
Form D private placements$900KraisedDec 2021 · 2 investors · Biotechnology
Rule 506(b)$3.2MraisedDec 2020 · 24 investors · Biotechnology
Rule 506(b)$4.3MraisedSep 2019 · 27 investors · Biotechnology
Rule 506(b)$4.5MraisedSep 2018 · 26 investors · Biotechnology
Rule 506(b)$356.2KraisedSep 2016 · 8 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.